Richard B Colletti

Summary

Affiliation: University of Vermont
Country: USA

Publications

  1. ncbi Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
    Thirumazhisai Gunasekaran
    Lutheran General Children s Hospital, Park Ridge, IL 60068, USA
    BMC Gastroenterol 9:84. 2009
  2. ncbi Overview of pediatric gastroesophageal reflux disease and proton pump inhibitor therapy
    Richard B Colletti
    Department of Pediatrics, University of Vermont College of Medicine, Burlington, Vermont, U S A
    J Pediatr Gastroenterol Nutr 37:S7-S11. 2003
  3. ncbi Variation in care in pediatric Crohn disease
    Richard B Colletti
    University of Vermont, Burlington, 05405 0068, USA
    J Pediatr Gastroenterol Nutr 49:297-303. 2009
  4. ncbi Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease
    Grace J Lee
    Pediatric Gastroenterology Fellowship Program, Nationwide Children s Hospital, Columbus, OH, USA
    J Pediatr Gastroenterol Nutr 55:701-6. 2012
  5. ncbi Short pediatric Crohn's disease activity index for quality improvement and observational research
    Michael D Kappelman
    Department of Pediatrics, University of North Carolina at Chapel Hill, North Carolina, USA
    Inflamm Bowel Dis 17:112-7. 2011
  6. ncbi Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease
    Truc Nguyen
    Department of Pediatrics, University of Vermont, Burlington, Vermont 05445 0068, USA
    Cancer Res 69:7004-12. 2009
  7. ncbi Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study
    Alessio Fasano
    Center for Celiac Research, University of Maryland School of Medicine, 22 S Greene St, N5W70, PO Box 140, Baltimore, MD 21201 1595, USA
    Arch Intern Med 163:286-92. 2003
  8. ncbi What outcome measures are needed to assess gastroesophageal reflux disease in children? what study design is appropriate? what new knowledge is needed?
    Benjamin D Gold
    J Pediatr Gastroenterol Nutr 37:S72-5. 2003
  9. ncbi Knowledge, attitudes and practice styles of North American pediatricians regarding gastroesophageal reflux disease
    Diego M Diaz
    Emory University School of Medicine, Atlanta, GA 30322, USA
    J Pediatr Gastroenterol Nutr 45:56-64. 2007

Collaborators

Detail Information

Publications9

  1. ncbi Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
    Thirumazhisai Gunasekaran
    Lutheran General Children s Hospital, Park Ridge, IL 60068, USA
    BMC Gastroenterol 9:84. 2009
    ..Therefore, the objective of the study was to examine the effect of GERD on HRQOL in adolescents...
  2. ncbi Overview of pediatric gastroesophageal reflux disease and proton pump inhibitor therapy
    Richard B Colletti
    Department of Pediatrics, University of Vermont College of Medicine, Burlington, Vermont, U S A
    J Pediatr Gastroenterol Nutr 37:S7-S11. 2003
    ..There is a critical need to evaluate PPI efficacy and safety in infants and children...
  3. ncbi Variation in care in pediatric Crohn disease
    Richard B Colletti
    University of Vermont, Burlington, 05405 0068, USA
    J Pediatr Gastroenterol Nutr 49:297-303. 2009
    ..Variation in medical care can be a barrier to improving clinical outcomes. We aim to describe the variation in care of Crohn disease as provided by a broad sample of pediatric gastroenterologists...
  4. ncbi Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease
    Grace J Lee
    Pediatric Gastroenterology Fellowship Program, Nationwide Children s Hospital, Columbus, OH, USA
    J Pediatr Gastroenterol Nutr 55:701-6. 2012
    ..To examine sex differences in medical therapy and clinical outcomes in pediatric patients with inflammatory bowel disease (IBD)...
  5. ncbi Short pediatric Crohn's disease activity index for quality improvement and observational research
    Michael D Kappelman
    Department of Pediatrics, University of North Carolina at Chapel Hill, North Carolina, USA
    Inflamm Bowel Dis 17:112-7. 2011
    ....
  6. ncbi Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease
    Truc Nguyen
    Department of Pediatrics, University of Vermont, Burlington, Vermont 05445 0068, USA
    Cancer Res 69:7004-12. 2009
    ..001). These findings provide in vivo evidence for mutation induction as a potential carcinogenic mechanism associated with chronic thiopurine intervention...
  7. ncbi Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study
    Alessio Fasano
    Center for Celiac Research, University of Maryland School of Medicine, 22 S Greene St, N5W70, PO Box 140, Baltimore, MD 21201 1595, USA
    Arch Intern Med 163:286-92. 2003
    ..The aim of this study was to determine the prevalence of CD in at-risk and not-at-risk groups in the United States...
  8. ncbi What outcome measures are needed to assess gastroesophageal reflux disease in children? what study design is appropriate? what new knowledge is needed?
    Benjamin D Gold
    J Pediatr Gastroenterol Nutr 37:S72-5. 2003
  9. ncbi Knowledge, attitudes and practice styles of North American pediatricians regarding gastroesophageal reflux disease
    Diego M Diaz
    Emory University School of Medicine, Atlanta, GA 30322, USA
    J Pediatr Gastroenterol Nutr 45:56-64. 2007
    ..Understanding the spectrum of management styles of GERD in children is critical to achieve better health outcomes and reduce health care costs...